HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dimitrios Pectasides Selected Research
Dimitrios Pectasides Research Topics
Disease
80
Neoplasms (Cancer)
01/2023 - 09/2003
59
Breast Neoplasms (Breast Cancer)
12/2023 - 07/2005
18
Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 02/2006
15
Neoplasm Metastasis (Metastasis)
01/2021 - 03/2005
11
Carcinoma (Carcinomatosis)
12/2022 - 06/2006
9
Disease Progression
03/2020 - 07/2005
9
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2019 - 09/2003
7
Melanoma (Melanoma, Malignant)
01/2016 - 12/2002
7
Ovarian Epithelial Carcinoma
01/2014 - 05/2005
6
Ovarian Neoplasms (Ovarian Cancer)
01/2014 - 10/2004
5
Adenocarcinoma
06/2021 - 02/2006
5
Febrile Neutropenia
07/2015 - 09/2003
4
Stomach Neoplasms (Stomach Cancer)
06/2021 - 01/2007
4
Triple Negative Breast Neoplasms
03/2021 - 01/2016
4
Colonic Neoplasms (Colon Cancer)
12/2019 - 01/2011
4
Neutropenia
07/2015 - 08/2004
4
Testicular Neoplasms (Testicular Cancer)
08/2012 - 09/2003
4
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2010 - 02/2004
3
Endometrial Neoplasms (Endometrial Cancer)
01/2019 - 10/2008
3
Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 12/2016
3
Anemia
01/2017 - 06/2008
3
Seminoma
06/2016 - 02/2004
3
Brain Neoplasms (Brain Tumor)
03/2006 - 01/2005
2
Squamous Cell Carcinoma of Head and Neck
01/2023 - 01/2013
2
Liver Diseases (Liver Disease)
01/2017 - 08/2013
Drug/Important Bio-Agent (IBA)
32
Paraffin
IBA
03/2021 - 02/2006
24
Proteins (Proteins, Gene)
FDA Link
12/2022 - 02/2006
24
Messenger RNA (mRNA)
IBA
01/2022 - 11/2006
24
Paclitaxel (Taxol)
FDA Link
Generic
01/2020 - 07/2005
21
Formaldehyde (Formol)
FDA Link
03/2021 - 07/2009
20
Biomarkers (Surrogate Marker)
IBA
01/2023 - 02/2005
16
Trastuzumab (Herceptin)
FDA Link
10/2022 - 09/2005
15
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 09/2003
15
Fluorouracil (Carac)
FDA Link
Generic
06/2021 - 10/2004
14
Carboplatin (JM8)
FDA Link
Generic
06/2016 - 09/2003
13
Anthracyclines
IBA
01/2022 - 01/2007
12
Platinum
IBA
12/2022 - 10/2004
11
Epirubicin (Ellence)
FDA Link
Generic
12/2023 - 01/2006
10
Docetaxel (Taxotere)
FDA Link
12/2023 - 01/2006
10
Oxaliplatin (Eloxatin)
FDA Link
Generic
12/2019 - 08/2004
9
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 07/2005
9
Gemcitabine
FDA Link
02/2020 - 09/2003
9
Irinotecan (Camptosar)
FDA Link
Generic
12/2019 - 09/2003
8
Leucovorin (Folinic Acid)
FDA Link
12/2019 - 10/2004
7
Cyclophosphamide (Cytoxan)
FDA Link
Generic
12/2023 - 01/2008
7
human ERBB2 protein
IBA
10/2022 - 06/2012
7
Methotrexate (Mexate)
FDA Link
Generic
01/2020 - 01/2010
7
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2015 - 04/2006
6
Hormones (Hormone)
IBA
01/2023 - 06/2006
6
Taxoids (Taxanes)
IBA
01/2022 - 07/2005
6
taxane
IBA
01/2017 - 10/2004
6
Progesterone Receptors (Progesterone Receptor)
IBA
11/2012 - 07/2009
6
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2010 - 09/2003
5
thiamine triphosphorate (TTP)
IBA
01/2022 - 09/2003
5
PTEN Phosphohydrolase (PTEN Phosphatase)
IBA
05/2020 - 05/2014
5
Bevacizumab (Avastin)
FDA Link
12/2019 - 09/2011
5
Capecitabine (Xeloda)
FDA Link
05/2018 - 03/2009
5
RNA (Ribonucleic Acid)
IBA
07/2015 - 11/2006
5
Estrogen Receptors
IBA
11/2012 - 07/2009
4
Phenobarbital (Luminal)
FDA Link
12/2022 - 01/2015
4
DNA (Deoxyribonucleic Acid)
IBA
02/2021 - 02/2006
4
Monoclonal Antibodies
IBA
11/2018 - 02/2013
4
Interferons
IBA
01/2016 - 12/2002
4
Vascular Endothelial Growth Factor C
IBA
09/2015 - 11/2006
4
Cetuximab (Erbitux)
FDA Link
05/2014 - 01/2013
4
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2013 - 01/2007
4
liposomal doxorubicin (Doxil)
FDA Link
01/2010 - 07/2005
3
Ligands
IBA
01/2022 - 06/2012
3
Protein Isoforms (Isoforms)
IBA
04/2021 - 10/2014
3
Cyclin D1
IBA
01/2019 - 12/2016
3
Growth Factor Receptors
IBA
12/2016 - 11/2007
3
Anti-Bacterial Agents (Antibiotics)
IBA
11/2010 - 09/2003
3
Interferon alpha-2 (Roferon-A)
FDA Link
02/2009 - 05/2004
2
Androgen Receptors (Androgen Receptor)
IBA
03/2021 - 01/2015
2
Epidermal Growth Factor (EGF)
IBA
01/2021 - 10/2011
2
Chemokines
IBA
01/2020 - 06/2012
2
Insulin-Like Growth Factor I (IGF-1)
IBA
08/2019 - 11/2018
2
Panitumumab (Vectibix)
FDA Link
05/2018 - 01/2016
2
entecavir
FDA Link
01/2017 - 01/2014
2
Osteopontin
IBA
01/2017 - 09/2015
2
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2017 - 01/2014
2
Iron
IBA
01/2017 - 02/2016
2
Keratin-5 (Keratin 5)
IBA
05/2016 - 01/2012
2
XELOX
IBA
01/2016 - 03/2009
2
Amino Acids
FDA Link
01/2016 - 01/2016
2
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
09/2015 - 07/2015
2
Filgrastim (Neupogen)
FDA Link
07/2015 - 01/2009
2
pegfilgrastim (Neulasta)
FDA Link
07/2015 - 01/2009
2
Vinblastine (Vinblastine Sulfate)
FDA Link
02/2015 - 01/2010
2
Temozolomide (Temodar)
FDA Link
Generic
02/2015 - 11/2006
Therapy/Procedure
61
Drug Therapy (Chemotherapy)
12/2023 - 09/2003
29
Adjuvant Chemotherapy
11/2022 - 07/2005
28
Therapeutics
06/2021 - 09/2003
4
Combination Drug Therapy (Combination Chemotherapy)
01/2016 - 02/2004
3
Radiotherapy
01/2013 - 01/2005
3
Neoadjuvant Therapy
06/2010 - 01/2005
2
Aftercare (After-Treatment)
01/2023 - 11/2006
2
Semiconductors
05/2016 - 01/2016
2
Treatment Delay
07/2015 - 01/2009
2
Drug Tapering
07/2015 - 01/2009